REFERENCES
- Ellison JM. Antidepressant-induced sexual dysfunction: re- view, classification, and suggestions for treatment. Harvard Rev Psychiatry 1998;6:177–89.
- Physicians’ desk reference. 51st ed. Montvale, New Jersey: Medical Economics, 1997.
- Montejo-Gonza´ lez AL, Llorca G, Izquierdo JA, Ledesma A, Bouson˜ o M, Calcedo A, et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a pro- spective, multicenter, and descriptive clinical study of 344 pa- tients. J Sex Marital Ther 1997;23:176–94.
- Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Inci- dence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001;62(suppl 3):10–21.
- Clayton AH, Leadbetter RA, Bass KI, Bolden-Watson CP, Donahue RMJ, Jamerson BD, et al. The prevalence of sexual dysfunction among patients currently taking new genera- tion antidepressants. Presented at the 39th annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2000.
- Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massa- chusetts Male Aging Study. Psychosom Med 1998;60:458–65.
- Lydiard RB, George MS. Fluoxetine-related anorgasmy [Let- ter]. South Med J 1989;82:933–4.
- Riley AJ, Riley EJ. Evaluation of drug effects on human sexual function. In: Riley AJ, Peet M, Wilson C, eds. Sexual pharma- cology. New York: Clarendon, 1993:114–29.
- Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 1999; 19:67–85.
- Zajecka J. Strategies for the treatment of antidepressant- related sexual dysfunction. J Clin Psychiatry 2001;62(suppl 3):35–43.
- Finkel MS, Laghrissi-Thode F, Pollock BG, Rong J. Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull 1996;32:653–8.
- Nurnberg HG, Gelenberg AJ, Fava M, Hensley PL, Lauriello J, Harrison W, et al. Sildenafil for SRI associated sexual dys- function: a three-center six weeks double blind placebo con- trolled study in 90 men. Presented at the 40th annual meeting of the NIMH New Clinical Drug Evaluation Unit, Boca Raton, Florida, May 2000.
- Woodrum ST, Brown CS. Management of SSRI-induced sexual dysfunction. Ann Pharmacother 1998;32:1209–15.
- Frankle WG, Nierenberg AA. An overview of the management of the side effects associated with newer treatments for mood disorders. J Clin Psychiatry [In press].
- Clayton AH, McGarvey EL, Warnock J, Kornstein S. Buprop- ion SR as an antidote to SSRI-induced sexual dysfunction. Presented at the 40th annual meeting of the NIMH New Clini- cal Drug Evaluation Unit, Boca Raton, Florida, May 2000.
- Lande´n M, Eriksson E, A° gren H, Fahle´n T. Effect of buspirone on sexual dysfunction in depressed patients treated with se- lective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268–71.
- Michelson D, Bancroft J, Targum S, Kim Y, Tepner R. Female sexual dysfunction associated with antidepressant adminis- tration: a randomized, placebo-controlled study of pharmaco- logic intervention. Am J Psychiatry 2000;157:239–43.
- Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, et al. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J Clin Psychiatry 2001;62:24–9.
- Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998;67:328–31.
- Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119–22.
- Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychia- try 1992;53:207–9.
- Berk M, Stein DJ, Potgieter A, Maud CM, Els C, Janet ML, Viljoen E. Serotonergic targets in the treatment of anti- depressant induced sexual dysfunction: a pilot study of grani- setron and sumatriptan. Int Clin Psychopharmacol 2000;15:291–5.
- Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant- induced sexual dysfunction. J Sex Marital Ther 1998;24:139–43.
- Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor–induced sexual dysfunction. J Clin Psychi- atry 1998;59:112–5.
- Rothschild AJ. Selective serotonin reuptake inhibitor–induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995;152:1514–6.
- Montejo AL, Llorca G, Izquierdo JA, Rico F, Daniel E. Switch- ing to nefazodone in patients with antidepressant-induced sexual dysfunction. Presented at the 152nd annual meeting of the American Psychiatric Association, Washington, DC, May 1999.
- Gelenberg AJ, Laukes C, McGahuey C, Okayli G, Moreno F, Zentner L, et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000;61:356–60.
- Walker PW, Cole JO, Gardner EA, Hughes AR, Johnson JA, Batey SR, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychia- try 1993;54:459–65.
- Farah A. Relief of SSRI-induced sexual dysfunction with mir- tazapine treatment [Letter]. J Clin Psychiatry 1999;60:260–1.
- Reynolds RD. Sertraline-induced anorgasmia treated with in- termittent nefazodone [Letter]. J Clin Psychiatry 1997;58:89.
- Nelson EB, Keck PE Jr, McElroy SL. Resolution of fluoxetine- induced sexual dysfunction with the 5-HT3 antagonist grani- setron [Letter]. J Clin Psychiatry 1997;58:496–7.
- Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants appar- ently reverse sexual dysfunction secondary to selective seroto- nin re-uptake inhibitors. J Sex Marital Ther 1995;21:264–71.
- Gitlin MJ. Treatment of sexual side effects with dopaminergic agents [Letter]. J Clin Psychiatry 1995;56:124.
- Roeloffs C, Bartlik B, Kaplan PM, Kocsis JH. Methylpheni- date and SSRI-induced sexual side effects [Letter]. J Clin Psy- chiatry 1996;57:548.
- Lauerma H. Successful treatment of citalopram-induced anor- gasmia by cyproheptadine. Acta Psychiatr Scand 1996;93:69–70.
- Keller Ashton A, Hamer R, Rosen RC. Serotonin reuptake inhibitor–induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997;23:165–75.
- Rosenberg KP. Sildenafil citrate for SSRI-induced sexual side effects [Letter]. Am J Psychiatry 1999;156:157.
- Schaller JL, Behar D. Sildenafil citrate for SSRI-induced sex- ual side effects [Letter]. Am J Psychiatry 1999;156:156–7.
- Reich J. The sexual side effects of an SSRI treated by behav- ioral methods. J Nerv Ment Dis 1997;185:707.
- Benazzi F, Mazzoli M. Fluoxetine-induced sexual dysfunction: a dose-dependent effect? Pharmacopsychiatry 1994;27:246.
- Dording CM, Bottonari KA, Hutchins AC, Alpert JE, Nieren- berg AA, Fava M. Sexual dysfunction during SSRI continua- tion treatment. Presented at the 153rd annual meeting of the American Psychiatric Association, Chicago, May 2000.
- Nierenberg AA. Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists. J Clin Psychiatry 1991;52:383–5.
- Byrne S, Rothschild AJ. Psychiatrists’ responses to failure of maintenance therapy with antidepressants. Psychiatr Serv 1997;48:835–7.
- Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med 2000;spec no:1–104.
- Mischoulon D, Fava M, Rosenbaum JF. Strategies for augmen- tation of SSRI treatment: a survey of an academic psychophar- macology practice. Harvard Rev Psychiatry 1999;6:322–6.
- Fava M. Management of nonresponse and intolerance: switch- ing strategies. J Clin Psychiatry 2000;61(suppl 2):10–12.
- Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation- retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose- response study. Br J Urol 1997;79:592–5.
- Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvox- amine, paroxetine, and sertraline. J Clin Psychopharmacol 1998;18:274–81.
- Michelson D, Fava M, Amsterdam J, Apter J, Londborg P, Ta- mura R, et al. Interruption of selective serotonin reuptake in- hibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry 2000;176:363–8.
- Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1990;51:25–7.